Michael J. Hayman
Affiliations: | Stony Brook University, Stony Brook, NY, United States |
Area:
Molecular Biology, Cell Biology, BiochemistryGoogle:
"Michael Hayman"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Jonine D. Figueroa | grad student | 2004 | SUNY Stony Brook |
| Kimberly J. Feres | grad student | 2009 | SUNY Stony Brook |
| Hongling Zhao | grad student | 2009 | SUNY Stony Brook |
| Namratha Sheshadri | grad student | 2014 | SUNY Stony Brook |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Klinghammer K, Keller J, George J, et al. (2017) A phosphoarray platform is capable of personalizing kinase inhibitor therapy in head and neck cancers. International Journal of Cancer |
| Ischenko I, Zhi J, Hayman MJ, et al. (2017) KRAS-dependent suppression of MYC enhances the sensitivity of cancer cells to cytotoxic agents. Oncotarget |
| Keller J, Nimnual AS, Varghese MS, et al. (2016) A Novel EGFR Extracellular Domain Mutant, EGFRdelta768, Possesses Distinct Biological and Biochemical Properties in Neuroblastoma. Molecular Cancer Research : McR |
| Ischenko I, Petrenko O, Hayman MJ. (2015) A MEK/PI3K/HDAC inhibitor combination therapy for KRAS mutant pancreatic cancer cells. Oncotarget. 6: 15814-27 |
| Rivas S, Armisén R, Rojas DA, et al. (2015) The Ski Protein is Involved in the Transformation Pathway of Aurora Kinase A. Journal of Cellular Biochemistry |
| Keller J, VanHeyst KA, Nimnual AS, et al. (2015) Abstract 3274: Neuroblastoma express a novel EGFR extracellular mutation, EGFRΔ768, which possesses distinct biological and biochemical properties Cancer Research. 75: 3274-3274 |
| Ischenko I, Liu J, Petrenko O, et al. (2014) Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells Cell Death and Differentiation. 21: 1218-1228 |
| Ischenko I, Petrenko O, Hayman MJ. (2014) Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas. Proceedings of the National Academy of Sciences of the United States of America. 111: 3466-71 |
| Ueki N, Lee S, Sampson NS, et al. (2013) Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease. Nature Communications. 4: 2735 |
| Keller J, Nimnual AS, Shroyer KR, et al. (2013) Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma. British Journal of Cancer. 109: 482-92 |